ACS Includes Cologuard in Prevention and Early Detection Guidelines
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read MorePosted by Steve Halasey | Nov 18, 2014 | Cancer, Molecular Diagnostics |
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
Read MorePosted by Steve Halasey | Aug 25, 2014 | Research |
Scientists at the Houston Methodist Research Institute have figured out how to pick up and transfer single cells using a pipette—a common laboratory tool that’s been tweaked slightly.
Read MorePosted by Jenny Lower | May 1, 2014 | Swabs, Uncategorized |
New products include high-throughput biobanking tubes from Greiner Bio-One, a centrifuge rotor from Beckman Coulter, and color-coded microbial test films from Neogen Corp.
Read MorePosted by Steve Halasey | Feb 25, 2014 | Cancer |
FDA has accepted a supplemental new drug application from Navidea Biopharmaceuticals, granting priority review for the expanded use of injection with Lymphoseek, as indicated for sentinel lymph node detection in patients with head and neck cancer.
Read MorePosted by Judy O'Rourke | Oct 8, 2013 | Cancer, Mass Spectrometry Reagents & Test Kits, Miscellaneous |
Improving the transfusion service’s ability to provide antigen-matched RBC units for alloimmunized patients.
Read More